Literature DB >> 15070127

Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome. Case report.

Atsushi Umemura1, Jurg L Jaggi, Carol A Dolinskas, Matthew B Stern, Gordon H Baltuch.   

Abstract

Generalized dystonia is one of the most disabling movement disorders. Ablative stereotactic surgery such as pallidotomy has been performed for medically refractory dystonia. Recently, deep brain stimulation (DBS) has appeared as an alternative to ablative procedures. Nevertheless, there have been few published reports detailing improvement in dystonia with DBS. This 36-year-old man with Hallervorden-Spatz syndrome suffered from intractable primary generalized dystonia for 28 years. He was completely dependent for activities of daily living and wheelchair bound because of continuous severe dystonic movements in the face, tongue, neck, trunk, and upper and lower extremities while at rest. The Burke-Fahn-Marsden (BFM) Dystonia Rating Scale score was 112 (maximum 120 points). Bilateral DBS of the globus pallidus internus was performed and resulted in marked improvement in motor functioning and dystonic symptoms with a significant reduction in disability. The BFM score improved to 22.5 points (80% improvement) at 3 months postsurgery and the patient's dystonia was still well suppressed 1 year after surgery. Bilateral pallidal stimulation is an effective and safe treatment for intractable generalized dystonia in Hallervorden-Spatz syndrome, even if the disability is severe and longstanding.

Entities:  

Mesh:

Year:  2004        PMID: 15070127     DOI: 10.3171/jns.2004.100.4.0706

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Pantothenate kinase-associated neurodegeneration with increased lentiform nuclei cerebral blood flow.

Authors:  M Koyama; A Yagishita
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

2.  Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.

Authors:  L Timmermann; K A M Pauls; K Wieland; R Jech; G Kurlemann; N Sharma; S S Gill; C A Haenggeli; S J Hayflick; P Hogarth; K L Leenders; P Limousin; C J Malanga; E Moro; J L Ostrem; F J Revilla; P Santens; A Schnitzler; S Tisch; F Valldeoriola; J Vesper; J Volkmann; D Woitalla; S Peker
Journal:  Brain       Date:  2010-03-05       Impact factor: 13.501

Review 3.  Arching deep brain stimulation in dystonia types.

Authors:  Han-Joon Kim; Beomseok Jeon
Journal:  J Neural Transm (Vienna)       Date:  2021-03-19       Impact factor: 3.575

4.  Clinical course of patients with pantothenate kinase-associated neurodegeneration (PKAN) before and after DBS surgery.

Authors:  Marina Svetel; Aleksandra Tomić; Nataša Dragašević; Igor Petrović; Nikola Kresojević; Robert Jech; Dušan Urgošik; Isidora Banjac; Jelena Vitković; Ivana Novaković; Vladimir S Kostić
Journal:  J Neurol       Date:  2019-08-29       Impact factor: 4.849

5.  Deep brain stimulation for medically refractory life-threatening status dystonicus in children.

Authors:  Brian P Walcott; Brian V Nahed; Kristopher T Kahle; Ann-Christine Duhaime; Nutan Sharma; Emad N Eskandar
Journal:  J Neurosurg Pediatr       Date:  2012-01       Impact factor: 2.375

6.  A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice.

Authors:  Yan Jiao; Xiudong Jin; Jian Yan; Chi Zhang; Feng Jiao; Xinmin Li; Bruce A Roe; David B Mount; Weikuan Gu
Journal:  Genomics       Date:  2008-03-14       Impact factor: 5.736

7.  An evaluation of rating scales utilized for deep brain stimulation for dystonia.

Authors:  Frandy Susatia; Irene A Malaty; Kelly D Foote; Samuel S Wu; Pamela R Zeilman; Mitushi Mishra; Ramon L Rodriguez; Ihtsham ul Haq; Charles E Jacobson; Anqi Sun; Michael S Okun
Journal:  J Neurol       Date:  2009-07-29       Impact factor: 4.849

Review 8.  Treatment of dystonia with deep brain stimulation.

Authors:  Jill L Ostrem; Philip A Starr
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

9.  Deep brain stimulation improves quality of life in pantothenate kinase-associated neurodegeneration.

Authors:  Kiran P Sathe; Anaita U Hegde; Paresh K Doshi
Journal:  J Pediatr Neurosci       Date:  2013-01

10.  Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).

Authors:  Susanne A Schneider; Petr Dusek; John Hardy; Ana Westenberger; Joseph Jankovic; Kailash P Bhatia
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.